Skip to main content
Fig. 5 | Journal of Hematology & Oncology

Fig. 5

From: Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

Fig. 5

Rational design for targeting mitochondria in cancer therapy. Drug repurposing, mitochondrial-targeted nanomedicines, and mitochondrial transplantation represent opportunity to offer promising strategies for targeting mitochondria to overcome cancer drug resistance. The mitochondrial inhibitors may be used in combination with chemotherapy, radiotherapy, or even immunotherapy to provide new avenues for cancer therapeutic regimes

Back to article page